Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Severe mosquito bite allergy: an unusual EBV+ NK cell lymphoproliferative disorder.

Said J, Smart C.

Blood. 2019 Feb 28;133(9):999. doi: 10.1182/blood-2018-11-886341. No abstract available.

PMID:
30819780
2.

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.

Kimura H, Fujiwara S.

Front Pediatr. 2019 Jan 4;6:417. doi: 10.3389/fped.2018.00417. eCollection 2018. Review.

3.

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S.

Blood. 2012 Jan 19;119(3):673-86. doi: 10.1182/blood-2011-10-381921. Epub 2011 Nov 16.

4.
5.

Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites.

Sakakibara Y, Wada T, Muraoka M, Matsuda Y, Toma T, Yachie A.

Cancer Sci. 2015 Aug;106(8):965-71. doi: 10.1111/cas.12696. Epub 2015 Jun 25.

6.

[The understanding of Epstein-Barr virus associated lymphoproliferative disorder].

Zhou XG, Zhang YL, Xie JL, Huang YH, Zheng YY, Li WS, Chen H, Liu F, Pan HX, Wei P, Wang Z, Hu YC, Yang KY, Xiao HL, Wu MJ, Yin WH, Mei KY, Chen G, Yan XC, Meng G, Xu G, Li J, Tian SF, Zhu J, Song YQ, Zhang WJ.

Zhonghua Bing Li Xue Za Zhi. 2016 Dec 8;45(12):817-821. doi: 10.3760/cma.j.issn.0529-5807.2016.12.001. Chinese.

PMID:
28056294
7.

Chronic active EBV infection: the experience of the Samsung Medical Center in South Korea.

Lee TH, Ko YH.

Bol Med Hosp Infant Mex. 2016 Jan - Feb;73(1):10-17. doi: 10.1016/j.bmhimx.2015.12.003. Epub 2016 Feb 1.

8.

NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.

Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K.

Am J Hematol. 2006 Aug;81(8):576-81.

9.

Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.

Park S, Ko YH.

J Dermatol. 2014 Jan;41(1):29-39. doi: 10.1111/1346-8138.12322. Review.

PMID:
24438142
10.

Overview of Epstein-Barr virus-associated diseases in Japan.

Wakiguchi H.

Crit Rev Oncol Hematol. 2002 Dec;44(3):193-202. Review.

PMID:
12467960
11.

Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.

Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.

Am J Dermatopathol. 2012 Dec;34(8):e119-24. doi: 10.1097/DAD.0b013e3181c036de.

PMID:
23169419
12.

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood.

Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, Park H.

Korean J Pathol. 2013 Apr;47(2):137-47. doi: 10.4132/KoreanJPathol.2013.47.2.137. Epub 2013 Apr 24.

13.

Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.

Yachie A, Kanegane H, Kasahara Y.

Semin Hematol. 2003 Apr;40(2):124-32. Review.

PMID:
12704589
14.

CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.

Asada H, Miyagawa S, Sumikawa Y, Yamaguchi Y, Itami S, Suguri S, Harada M, Tokura Y, Ishihara S, Ohshima S, Yoshikawa K.

Arch Dermatol. 2003 Dec;139(12):1601-7.

PMID:
14676078
15.

Atypical hypersensitivity to mosquito bites without natural killer cell proliferative disease in an adult patient.

Konuma T, Uchimaru K, Sekine R, Ohno N, Soda Y, Tomonari A, Ooi J, Nagamura F, Takahashi S, Iseki T, Oyaizu N, Tojo A, Asano S.

Int J Hematol. 2005 Dec;82(5):441-4.

PMID:
16533749
16.

Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia.

Washio K, Oka T, Abdalkader L, Muraoka M, Shimada A, Oda M, Sato H, Takata K, Kagami Y, Shimizu N, Kato S, Kimura H, Nishizaki K, Yoshino T, Tsukahara H.

Leuk Lymphoma. 2017 Nov;58(11):2683-2694. doi: 10.1080/10428194.2017.1304762. Epub 2017 Apr 3.

PMID:
28367723
17.

Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES.

Ann Oncol. 2009 Sep;20(9):1472-82. doi: 10.1093/annonc/mdp064. Epub 2009 Jun 10.

18.

Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.

Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.

Int J Oncol. 2004 May;24(5):1165-74.

PMID:
15067338
19.

Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.

Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.

Bone Marrow Transplant. 2003 Jan;31(2):105-11.

PMID:
12621491
20.

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK; CAEBV Study Group.

Pathol Int. 2008 Apr;58(4):209-17. doi: 10.1111/j.1440-1827.2008.02213.x. Review.

PMID:
18324913

Supplemental Content

Support Center